• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Amar Bhakta Explains a New Pathway to Prevent Heart Failure Readmissions

Video

A new pathway uses a multidisciplinary team to help reduce 30-day heart failure readmissions, explained Amar Bhakta, MD, of Rush University Medical Center.

A new pathway uses a multidisciplinary team to help reduce 30-day heart failure readmissions, explained Amar Bhakta, MD, of Rush University Medical Center.

Transcript

What was the pathway to prevent heart failure readmissions that you presented at the American Heart Association Scientific Sessions?

This pathway came about just because with the increase in healthcare costs, ways to reduce healthcare costs, especially with heart failure readmissions, I think what we found was we were able to reduce it if we developed a multidisciplinary team. And using that team over a period of 6 months, we found that we were able to reduce heart failure 30-day readmissions from 22% down to 16%.

Who are the team members in the multidisciplinary pathway and what were their roles?

The multidisciplinary team included a heart failure specialist, other physicians, pharmacists, social workers, nurses, and nurse practitioners. We designed a pathway from inpatient admission all the way up to discharge and then beyond discharge, as well, and outpatient setting, including following up with a nurse practitioner, a heart failure nurse practitioner specialist, within 7 days, and then with their PCP within 3 weeks.

Related Videos
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Kimberly Westrich, MA, chief strategy officer, NPC
Marla Black Morgan, MD, Phoebe Neurology Associates
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Joseph Saseen, PharmD
Bridgette Picou, LVN, ACLPN, The Well Project
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.